Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

COPAN DIAGNOSTICS

COPAN (which stands for COllection and Preservation for ANalysis) is a global market leader in sample collection and ... read more Featured Products: More products

Download Mobile App




Fully Automated System Transforms Pre-Analytical Handling of Urine Specimens

By LabMedica International staff writers
Posted on 14 Aug 2025

Urine specimens make up a substantial portion of a laboratory’s daily workload, yet essential pre-analytical steps such as aliquoting are often still done manually. More...

These manual processes are time-consuming, prone to error, and limit efficiency as testing volumes grow. Now, a new fully automated platform addresses these challenges by streamlining the handling of urine specimens from start to finish.

Copan Diagnostics (Murrieta, CA, USA) has introduced UriVerse, an advanced system that automates key steps, including decapping, precise aliquoting, barcode labeling, and recapping of secondary tubes. Vision-guided technology identifies containers, performs de-capping without manual sorting, and transfers up to 10 mL into as many as nine secondary tubes.

The system eliminates manual pipetting and sorting with continuous, random-access loading, cup recognition, and fully integrated labeling and capping. By automating these processes, UriVerse improves traceability, reduces variability, and integrates seamlessly into existing laboratory workflows. UriVerse is designed to meet the demands of chemistry, toxicology, and other high-volume urine testing.

UriVerse is especially suited for laboratories facing increasing volume, staff shortages, and pressure for faster turnaround times. By reducing hands-on time and minimizing errors, the system supports greater efficiency and consistency in urine testing. Its ability to handle growing specimen volumes with accuracy makes it a valuable tool for modern laboratory operations. UriVerse is designed to fit easily into existing laboratory workflows.

"With UriVerse, we offer an efficient, accurate solution to help laboratories meet rising urine testing demands while reducing variability through automation of manual pre-analytical tasks," said Fabrizio Mazzocchi, CEO of Copan Diagnostics.

Related Links:
Copan Diagnostics 


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.